Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
GADD45A is a protective modifier of neurogenic skeletal muscle atrophy
Jeffrey T. Ehmsen, Riki Kawaguchi, Damlanur Kaval, Anna E. Johnson, Daniel Nachun, Giovanni Coppola, Ahmet Höke
Jeffrey T. Ehmsen, Riki Kawaguchi, Damlanur Kaval, Anna E. Johnson, Daniel Nachun, Giovanni Coppola, Ahmet Höke
View: Text | PDF
Research Article Muscle biology Neuroscience

GADD45A is a protective modifier of neurogenic skeletal muscle atrophy

  • Text
  • PDF
Abstract

Neurogenic muscle atrophy is the loss of skeletal muscle mass and function that occurs with nerve injury and in denervating diseases, such as amyotrophic lateral sclerosis. Aside from prompt restoration of innervation and exercise where feasible, there are currently no effective strategies for maintaining skeletal muscle mass in the setting of denervation. We conducted a longitudinal analysis of gene expression changes occurring in atrophying skeletal muscle and identified growth arrest and DNA damage-inducible A (Gadd45a) as a gene that shows one of the earliest and most sustained increases in expression in skeletal muscle after denervation. We evaluated the role of this induction using genetic mouse models and found that mice lacking GADD45A showed accelerated and exacerbated neurogenic muscle atrophy, as well as loss of fiber type identity. Our genetic analyses demonstrate that, rather than directly contributing to muscle atrophy as proposed in earlier studies, GADD45A induction likely represents a protective negative feedback response to denervation. Establishing the downstream effectors that mediate this protective effect and the pathways they participate in may yield new opportunities to modify the course of muscle atrophy.

Authors

Jeffrey T. Ehmsen, Riki Kawaguchi, Damlanur Kaval, Anna E. Johnson, Daniel Nachun, Giovanni Coppola, Ahmet Höke

×

Figure 3

Denervation induces Gadd45a expression specifically in skeletal muscle myocytes.

Options: View larger image (or click on image) Download as PowerPoint
Denervation induces Gadd45a expression specifically in skeletal muscle m...
Skeletal muscle–specific deletion of Gadd45a (HSA-Cre:Gadd45afl) essentially abolished its induction in denervated gastrocnemius compared with Gadd45afl and WT littermates (A and B, paired t test). Error bars in A show mean ± SEM. Accordingly, a target corresponding to endogenous V5 epitope–tagged GADD45A was detected in denervated gastrocnemius from Gadd45afl mice (but not contralateral intact muscle) but was abolished in denervated HSA-Cre:Gadd45afl gastrocnemius (C). Baseline gastrocnemius and soleus muscle mass from WT, heterozygous, Gadd45afl, HSA-Cre:Gadd45afl (muscle-specific Gadd45a deletion), and CMV-Cre:Gadd45afl (ubiquitous Gadd45a deletion) did not significantly differ (D–H and N; soleus muscle shown, scale bar: 300 μm). However, at 14 days postdenervation, gastrocnemius and soleus muscle from HSA-Cre:Gadd45afl mice showed significantly greater loss of mass compared with WT, heterozygous, and Gadd45afl genotypes (I–M and O, 1-way ANOVA with Bonferroni’s correction). The degree of gastrocnemius and soleus mass loss in CMV-Cre:Gadd45afl mice does not significantly differ from HSA-Cre:Gadd45afl mice, consistent with the inference that the protective effect of Gadd45a induction is mediated entirely through its expression in skeletal muscle myocytes. The box plots depict the minimum and maximum values (whiskers), the upper and lower quartiles, and the median. The length of the box represents the interquartile range.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts